It has been reported that breast cancer cells express elevated levels of LPAR1, LPAR2, and LPAR3 and that these LPA receptors are involved in stimulating tumorigenic and metastatic cascades via Wnt, MAPK, and PI3K pathways. Here, LPAR2 is linked to breast cancer.